A trial in healthy volunteers to study safety, tolerability, CS014-levels and effects in the body, after single and repeated doses of CS014, for the first time in humans.
This study is a very early stage trial looking at a new medicine called CS014. It's the first time this medicine will be given to people. Researchers want to make sure it's safe and that people can take it without serious problems. They will give participants a single dose and then repeated doses of CS014 to understand how the medicine behaves in the body and what effects it might have. This research is important because it could lead to new ways of treating conditions that affect the heart and blood vessels, like heart attacks or strokes. Participants will be healthy adult volunteers, and their safety will be the top priority throughout the study.
At a glance
What is this study about?
This study is a very important first step in developing a new medicine. Think of it like testing out a new car engine for the very first time – you want to make sure it runs safely before you put it into a real car and take it on the road. In this case, the 'new car engine' is a medicine called CS014, and the 'road' is treating people with specific illnesses.
Researchers will be giving CS014 to healthy volunteers. They want to find out how safe it is, whether people can take it without too many side effects, and how much of the medicine stays in the body and for how long. They will also look generally at what effects the medicine has inside the body. This helps them understand the best way to use the medicine in the future.
Finding new medicines is a long process, and this 'Phase I' study is right at the beginning. The goal is to gather crucial safety information. If CS014 proves to be safe and behaves as expected in healthy people, it could then potentially be studied further in people with actual heart and blood vessel conditions, offering a new hope for treatment in the future.
Key takeaways
- This is the first human trial of a new medicine, CS014.
- The main goal is to check safety and how the body handles the medicine.
- It's for healthy adults aged 18 and over.
- Participation involves clinic visits, taking the medicine, and health checks.
- Your health and safety are the top priority.
- You contribute to future treatments for heart and blood vessel conditions.
Who may be eligible?
To join this study, you need to be a healthy adult, aged 18 years or older. The study is open to both men and women.
The research team is looking for people who are generally well and don't have existing health problems. This is because they want to see how the new medicine affects the body without other health conditions getting in the way.
Specific health checks will be done by the study doctors to make sure it's safe for you to take part. For example, they will check your heart, blood pressure, and blood tests to confirm you are healthy enough for the study.
- Are you 18 years old or older?
- Are you generally healthy with no serious existing medical conditions?
- Are you able to attend several appointments at a research clinic?
- Are you willing to take a new, untested medicine?
- Are you happy to have regular blood tests and health checks?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you decide to take part, you would first have a screening visit to check if you are suitable. This involves a health check, blood tests, and other assessments. If you meet all the requirements, you would then come to the research clinic for several visits.
During these visits, you would be given the study medicine, CS014, either as a single dose first, and later, repeated doses over a period of time. The research team will regularly check on you, take blood samples, measure your heart rate and blood pressure, and ask about any side effects you might be feeling. You might need to stay at the clinic overnight for some parts of the study. After your last dose, there will be follow-up visits to ensure your health is good and to continue monitoring the medicine's effects. The total time you spend in the study, from your first visit to your last follow-up, will be explained fully by the study team.
Potential risks and benefits
Locations (1)
- —Sweden
Common questions
What kind of medicine is CS014?
CS014 is a new medicine being developed to potentially treat conditions affecting the heart and blood vessels. This study is the very first time it will be given to humans.
Will I get paid for taking part?
Many clinical trials offer some payment for your time, travel, and inconvenience. This will be fully explained to you by the study team before you decide to join.
What does 'Phase I' mean?
Phase I is the first stage of testing a new medicine in humans. It focuses on checking if the medicine is safe and how the body handles it, usually in healthy volunteers.
Will this medicine cure my heart condition?
This study is a very early stage and involves healthy volunteers; it is not yet testing for cures. The aim is to gather safety information before considering testing in people with specific conditions.
How long will I be in the study?
The exact duration of your participation, including visits and follow-ups, will be clearly explained by the research team if you are eligible and interested.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.